PAYAL PARDIWALA: Open Payments
NPI 1902413198 · TURLOCK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 60 payments from 19 companies in 2025. Trend: 2023 $490 · 2024 $576 · 2025 $1,278
Food & beverage: $1,254Education: $24
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $231 |
| ABBVIE INC. | 11 | $186 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $162 |
| REVANCE THERAPEUTICS, INC. | 4 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
| Incyte Corporation | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| STRATA Skin Sciences, Inc. | 4 | $37 |
| UCB, Inc. | 1 | $34 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, ILUMYA, OPZELURA, DAXXIFY, Sotyktu, Rhapsido.
Industry payments across CA — which companies pay providers there.
